Cytoprotective properties of nisoldipine and amlodipine against oxidative endothelial cell injury

Annals of the New York Academy of Sciences

Volumn 899, Issue , 2000, Pages 403-406

  Mak, I Tong ^a,b   Zhang, Jingyun ^a   Weglicki, William B ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b Ross Hall ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; NISOLDIPINE; TROLOX C;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; AORTA; ARTERY ENDOTHELIUM; CATTLE; CELL DAMAGE; CELL PROTECTION; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; NONHUMAN; OXIDATION;

EID: 0034046616     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06204.x     Document Type: Conference Paper

References (8)

1. 1. Ross, R. 1986. The pathogenesis of atherosclerosis: an update. N. Engl. J. Med. 314: 488-500
2. 2. HENNING, B. & C.K. CHOW. 1988. Lipid peroxidation and endothelial cell injury: Implications in atherosclerosis. Free Rad. Biol. Med. 4: 99-106.
3. 3. WEINSTEIN, D.B. & J.G. HEIDER. 1988. Antiatherogenic properties of calcium channel blockers. Am. J. Med. 84 (Suppl. 3B): 102-108.
4. 4. KEOGH, A.M. & J.S. SCHROEDER. 1990. Calcium antagonists and atherosclerosis. Reperfusion 2: 5-8.
5. 5. MAK, I.T. et al. 1992. Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells. Circ. Res. 70: 1099-1103.
6. 6. MAK, I.T. et al. 1992. Antioxidant properties of active and inactive isomers of nicardipine in cardiac membranes, endothelial cells, and perfused rat hearts. Coronary Artery Dis. 3: 1095-1103.
7. 7. MAK, I.T. & W.B. WEGLICKI. 1994. Antioxidant activity of calcium channel blocking drugs. Methods Enzymol. 234: 620-630.
8. 8. MAK, I.T. et al. 1995. Protective effects of calcium channel blockers against free radical-impaired endothelial cell proliferation. Biochem. Pharmacol. 50: 1531-1534.